Similar Items: Rifampicin-resistant tuberculosis in Botswana: barriers and risk factors influencing patient outcomes, case detection, and linkage to effective care and treatment
- Rifampicin-resistant Mycobacterium tuberculosis: an emerging threat to human health in Botswana
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Hepatocellular injury in children treated for rifampicin-resistant tuberculosis: incidence, aetiology and outcome
- Regulation of efflux in rifampicin resistant mutants of Mycobacterium tuberculosis
- The efficacy of mycolic acid-enhanced PLGA nanoparticles for rifampicin delivery in tuberculosis treatment
- The Epidemiology and Evolution of Rifampicin Mono Resistant Tuberculosis in Khayelitsha, Cape Town, South Africa
Author: Cox, Helen
- Baseline prevalence and incidence and risk factors for new-onset drug induced hearing loss in adults receiving drug-resistant tuberculosis (DR-TB) treatment in Khayelitsha, South Africa
- The Epidemiology and Evolution of Rifampicin Mono Resistant Tuberculosis in Khayelitsha, Cape Town, South Africa
- Rifampicin-resistant tuberculosis in Botswana: barriers and risk factors influencing patient outcomes, case detection, and linkage to effective care and treatment